Enanta Pharmaceuticals, Inc. · NASDAQ:ENTA

Integrated Core Strategies (US) LLC's stake in Enanta Pharmaceuticals, Inc. fell to 2.30% (Schedule 13G/A)

Event Dec 31, 2025 · Filed Jan 20, 2026

Integrated Core Strategies (US) LLC's stake in Enanta Pharmaceuticals, Inc. fell to 2.30%, 665,953 shares, as a passive investor on Dec 31, 2025. Filed Jan 20, 2026 (Schedule 13G/A).

Stake
2.30%
Shares
665,953
Intent
Passive
What changed
Fell below 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Integrated Core Strategies (US) LLC2.30%665,953
Millennium Management LLC2.30%670,428
Millennium Group Management LLC2.30%670,428
Israel A. Englander2.30%670,428

Source

View original at SEC

Related